Lynelle Hoch insider trades
Open-market stock purchases and sales by Lynelle Hoch, President, Cell Therapy Org. at Bristol Myers Squibb Co, from SEC Form 4 filings since Mar 10, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $16.1K |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $12.7K |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $54.8K |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
Companies traded
- BMY Bristol Myers Squibb Co: other filings, last Mar 10, 2026